PMID	Title	DOI	Journal	Year	Volume	Issue	Total_author_count	Affiliated_author_count	Affiliated_author_names	Affilated_author_affiliations	Is_valid_hit	Affiliated_author_affiliations
35604410	Multi-institutional study of the frequency, genomic landscape and outcome of IDH-mutant glioma in paediatrics.	10.1093/neuonc/noac132	Neuro-oncology	2022			32.0	1.0	Kaneva_Kristiyana			tempus labs, inc.
35263765	Researching Compassionate Communities from an interdisciplinary perspective: the case of the Compassionate Communities Centre of Expertise (COCO).	10.1093/geront/gnac034	The Gerontologist	2022			15.0	2.0	Van_Droogenbroeck_Filip; Spruyt_Bram			tempus omnia revelat, vrije universiteit brussel (vub), brussels, belgium.; tempus omnia revelat, vrije universiteit brussel (vub), brussels, belgium.
35171659	Real-World Experience of <i>NTRK</i> Fusion-Positive Thyroid Cancer.	10.1200/PO.21.00442	JCO precision oncology	2022	6.0		4.0	1.0	Ashok_Arya			medical affairs, tempus, phoenix, az.
35134211	Racial and Ethnic Differences in Genomic Profiling of Early Onset Colorectal Cancer.	10.1093/jnci/djac014	Journal of the National Cancer Institute	2022	114.0	5	11.0	2.0	Rhead_Brooke; De_La_Vega_Francisco_M			tempus labs, inc, chicago, il, usa.; tempus labs, inc, chicago, il, usa.
34998516	Continuous action deep reinforcement learning for propofol dosing during general anesthesia.	10.1016/j.artmed.2021.102227	Artificial intelligence in medicine	2022	123.0		5.0	1.0	Badgeley_Marcus			tempus, chicago, il 60654, usa.
34979999	Landscape of homologous recombination deficiencies in solid tumours: analyses of two independent genomic datasets.	10.1186/s12885-021-09082-y	BMC cancer	2022	22.0	1	8.0	1.0	Dry_Jonathan_R			present address: tempus labs inc., boston, ma, usa.
34801336	"Corrigendum to ""Identification of Differential Tumor Subtypes of T1 Bladder Cancer"" [Eur. Urol. 78 (2020) 533-537]."	10.1016/j.eururo.2021.11.001	European urology	2022	81.0	2	17.0	1.0	Taxter_Timothy_J			tempus labs, inc., chicago, il, usa.
34663898	Predicting cancer outcomes with radiomics and artificial intelligence in radiology.	10.1038/s41571-021-00560-7	Nature reviews. Clinical oncology	2022	19.0	2	5.0	1.0	Braman_Nathaniel			tempus labs, chicago, il, usa.
34714709	Exercise is Medicine: Implementing a New Initiative to Increase Patients' Activity and Functional Mobility in Pediatric Stem-Cell Transplant Unit.	10.1200/OP.21.00199	JCO oncology practice	2022	18.0	3	6.0	1.0	Munger_Jessica			tempus labs biotechnology, chicago, il.
34664259	The Friends of Cancer Research Real-World Data Collaboration Pilot 2.0: Methodological Recommendations from Oncology Case Studies.	10.1002/cpt.2453	Clinical pharmacology and therapeutics	2022	111.0	1	27.0	2.0	Honnold_Rebecca; Pe_Benito_Ruth			tempus, chicago, illinois, usa.; tempus, chicago, illinois, usa.
35233056	Crizotinib in patients with tumors harboring ALK or ROS1 rearrangements in the NCI-MATCH trial.	10.1038/s41698-022-00256-w	NPJ precision oncology	2022	6.0	1	29.0	1.0	Malik_N			tempus, chicago, il, usa.
34794190	Systematic Review and Meta-Analysis of L-Methylfolate Augmentation in Depressive Disorders.	10.1055/a-1681-2047	Pharmacopsychiatry	2022	55.0	3	5.0	1.0	Brown_Lisa_C			tempus labs, chicago, il, usa.
35620075	Protocol for drug screening of patient-derived tumor organoids using high-content fluorescent imaging.	10.1016/j.xpro.2022.101407	STAR protocols	2022	3	2	4.0	4.0	Larsen_Brian_M; Cancino_Andrea; Shaxted_Jenna_M; Salahudeen_Ameen_A			tempus labs, inc, chicago, il 60654, usa.; tempus labs, inc, chicago, il 60654, usa.; tempus labs, inc, chicago, il 60654, usa.; tempus labs, inc, chicago, il 60654, usa.
35274707	Homologous Recombination Deficiency: Concepts, Definitions, and Assays.	10.1093/oncolo/oyab053	The oncologist	2022	27.0	3	25.0	2.0	Beaubier_Nike; Parsons_Jerod			tempus labs, inc., chicago, il, usa.; tempus labs, inc., chicago, il, usa.
35339649	Phase 2 single arm study of nivolumab and ipilimumab (Nivo/Ipi) in previously treated classical Kaposi Sarcoma (cKS).	10.1016/j.annonc.2022.03.012	Annals of oncology : official journal of the European Society for Medical Oncology	2022			19.0	1.0	Schwarzbach_A_E			tempus labs, chicago, il, usa.
35319967	Landscape of <i>KRAS</i><sup>G12C</sup>, Associated Genomic Alterations, and Interrelation With Immuno-Oncology Biomarkers in <i>KRAS</i>-Mutated Cancers.	10.1200/PO.21.00245	JCO precision oncology	2022	6.0		15.0	3.0	El-Refai_Sherif_M; O'Neil_Bert; Barrett_Alexander_S			tempus labs inc, chicago, il.; tempus labs inc, chicago, il.; tempus labs inc, chicago, il.
35416393	Exploring United States genetic counselor and healthcare interpreter perspectives: Allocation of roles within the genetic counseling encounter.	10.1002/jgc4.1572	Journal of genetic counseling	2022			6.0	1.0	Stoll_Jessica			tempus labs, chicago, illinois, usa.
35474001	Author Correction: Expanded encyclopaedias of DNA elements in the human and mouse genomes.	10.1038/s41586-021-04226-3	Nature	2022	605.0	7909	63.0	1.0	White_Kevin_P			tempus labs, chicago, il, usa.
35538548	Refining colorectal cancer classification and clinical stratification through a single-cell atlas.	10.1186/s13059-022-02677-z	Genome biology	2022	23.0	1	31.0	3.0	Rand_Tim; Khare_Sonal; Salahudeen_Ameen_A			tempus labs, inc., chicago, il, usa.; tempus labs, inc., chicago, il, usa.; tempus labs, inc., chicago, il, usa.
35388408	Privacy preserving validation for multiomic prediction models.	10.1093/bib/bbac110	Briefings in bioinformatics	2022	23.0	3	9.0	9.0	Ahmed_Talal; Carty_Mark_A; Wenric_Stephane; Dry_Jonathan_R; Salahudeen_Ameen_A; Khan_Aly_A; Lefkofsky_Eric; Stumpe_Martin_C; Pelossof_Raphael			tempus labs inc., chicago, il 60654, usa.; tempus labs inc., chicago, il 60654, usa.; tempus labs inc., chicago, il 60654, usa.; tempus labs inc., chicago, il 60654, usa.; tempus labs inc., chicago, il 60654, usa.; tempus labs inc., chicago, il 60654, usa.; tempus labs inc., chicago, il 60654, usa.; tempus labs inc., chicago, il 60654, usa.; tempus labs inc., chicago, il 60654, usa.
35584967	COVID-19 vaccine effectiveness in patients with hematologic malignancy.	10.1111/tid.13850	Transplant infectious disease : an official journal of the Transplantation Society	2022			3.0	1.0	Thompson_Michael_A			tempus labs, chicago, il.
35594047	Prevalence of Germline Findings Among Tumors From Cancer Types Lacking Hereditary Testing Guidelines.	10.1001/jamanetworkopen.2022.13070	JAMA network open	2022	5.0	5	8.0	5.0	Ashok_Arya; Stoll_Jessica; Mauer_Elizabeth; Nepomuceno_Vanessa_M; Blackwell_Kimberly_L			tempus labs inc, chicago, illinois.; tempus labs inc, chicago, illinois.; tempus labs inc, chicago, illinois.; tempus labs inc, chicago, illinois.; tempus labs inc, chicago, illinois.
35533093	rECHOmmend: An ECG-based Machine-learning Approach for Identifying Patients at High-risk of Undiagnosed Structural Heart Disease Detectable by Echocardiography.	10.1161/CIRCULATIONAHA.121.057869	Circulation	2022			14.0	8.0	Pfeifer_John_M; Raghunath_Sushravya; Leader_Joseph_B; Zimmerman_Noah; Lee_Greg; Steinhubl_Steven_R; Fornwalt_Brandon_K; Chen_RuiJun			department of translational data science and informatics, geisinger, danville, pa; heart and vascular center, evangelical hospital, lewisburg, pa; tempus labs inc, chicago, il.; department of translational data science and informatics, geisinger, danville, pa; tempus labs inc, chicago, il.; phenomic analytics and clinical data core, geisinger, danville, pa; tempus labs inc, chicago, il.; tempus labs inc, chicago, il.; tempus labs inc, chicago, il.; tempus labs inc, chicago, il; scripps research translational institute, la jolla, ca.; department of translational data science and informatics, geisinger, danville, pa; tempus labs inc, chicago, il; heart institute, geisinger, danville, pa; department of radiology, geisinger, danville, pa.; department of translational data science and informatics, geisinger, danville, pa; tempus labs inc, chicago, il; department of medicine, geisinger, danville, pa.
35593483	Comprehensive genomic profiling in advanced/metastatic colorectal cancer: number needed to test and budget impact of expanded first line use.	10.1080/13696998.2022.2080463	Journal of medical economics	2022			7.0	2.0	Belinson_Suzanne; Allo_Mina_Alsaraf			tempus labs, inc., chicago, il.; tempus labs, inc., chicago, il.
33619265	Longitudinal and multi-tissue molecular diagnostics track somatic BRCA2 reversion mutations that correct the open reading frame of germline alteration upon clinical relapse.	10.1038/s41525-021-00181-0	NPJ genomic medicine	2021	6.0	1	4.0	3.0	Sorrells_Shelly; McKinnon_Kelly_E; McBratney_Ashleigh			tempus laboratories, chicago, il, usa.; tempus laboratories, chicago, il, usa.; tempus laboratories, chicago, il, usa.
33731690	Non-secretory multiple myeloma with unusual TFG-ALK fusion showed dramatic response to ALK inhibition.	10.1038/s41525-021-00186-9	NPJ genomic medicine	2021	6.0	1	14.0	1.0	Salahudeen_Ameen			tempus labs, inc, chicago, il, usa.
33652561	Preclinical Evaluation of Artesunate as an Antineoplastic Agent in Ovarian Cancer Treatment.	10.3390/diagnostics11030395	Diagnostics (Basel, Switzerland)	2021	11.0	3	8.0	2.0	Zhang_Yilin; Salahudeen_Ameen_A			tempus labs, 600 w chicago ave. ste 510, chicago, il 60654, usa.; tempus labs, 600 w chicago ave. ste 510, chicago, il 60654, usa.
32972830	First-in-Human Phase 1b Trial of Quinacrine Plus Capecitabine in Patients With Refractory Metastatic Colorectal Cancer.	10.1016/j.clcc.2020.08.003	Clinical colorectal cancer	2021	20.0	1	19.0	1.0	White_Kevin			tempus, chicago, il.
33637709	Chromatin information content landscapes inform transcription factor and DNA interactions.	10.1038/s41467-021-21534-4	Nature communications	2021	12.0	1	7.0	1.0	Kyono_Yasuhiro			tempus labs, inc. chicago, il, chicago, usa.
33637494	Successful use of immunotherapy to treat advanced cutaneous squamous cell carcinoma in recessive dystrophic epidermolysis bullosa.	10.1136/bcr-2020-238966	BMJ case reports	2021	14.0	2	4.0	1.0	Barrett_Alexander			tempus labs inc, chicago, illinois, usa.
33625877	OncoTree: A Cancer Classification System for Precision Oncology.	10.1200/CCI.20.00108	JCO clinical cancer informatics	2021	5.0		66.0	1.0	Sanchez_Iker_Huerga			tempus labs inc, new york, ny.
33300245	Specifications of the ACMG/AMP variant interpretation guidelines for germline TP53 variants.	10.1002/humu.24152	Human mutation	2021	42.0	3	23.0	1.0	Huether_Robert			tempus, chicago, illinois, usa.
33875798	Interpretable survival prediction for colorectal cancer using deep learning.	10.1038/s41746-021-00427-2	NPJ digital medicine	2021	4.0	1	23.0	1.0	Stumpe_Martin_C			google health, tempus labs inc., chicago, il, usa.
33337916	Contemporary Clinical Trials Office: Doing More With Less.	10.1200/OP.20.00871	JCO oncology practice	2021	17.0	1	2.0	1.0	Carson_Kenneth_R			tempus labs, inc., chicago, il.
33594373	Early introductions and community transmission of SARS-CoV-2 variant B.1.1.7 in the United States.	10.1101/2021.02.10.21251540	medRxiv : the preprint server for health sciences	2021			50.0	7.0	MacKay_Matthew_J; Khullar_Gaurav; Metti_Jessica; Dudley_Joel_T; Nash_Megan; Beaubier_Nike; Mason_Christopher_E			tempus labs, chicago, il 60654, usa.; tempus labs, chicago, il 60654, usa.; tempus labs, chicago, il 60654, usa.; tempus labs, chicago, il 60654, usa.; tempus labs, chicago, il 60654, usa.; tempus labs, chicago, il 60654, usa.; tempus labs, chicago, il 60654, usa.
33891875	Early introductions and transmission of SARS-CoV-2 variant B.1.1.7 in the United States.	10.1016/j.cell.2021.03.061	Cell	2021	184.0	10	50.0	7.0	MacKay_Matthew_J; Khullar_Gaurav; Metti_Jessica; Dudley_Joel_T; Nash_Megan; Beaubier_Nike; Mason_Christopher_E			tempus labs, chicago, il 60654, usa.; tempus labs, chicago, il 60654, usa.; tempus labs, chicago, il 60654, usa.; tempus labs, chicago, il 60654, usa.; tempus labs, chicago, il 60654, usa.; tempus labs, chicago, il 60654, usa.; tempus labs, chicago, il 60654, usa; department of pathology and laboratory medicine, new york presbyterian hospital-weill cornell medicine, new york, ny 10021, usa.
33446413	Real-world Evidence of Diagnostic Testing and Treatment Patterns in US Patients With Breast Cancer With Implications for Treatment Biomarkers From RNA Sequencing Data.	10.1016/j.clbc.2020.11.012	Clinical breast cancer	2021	21.0	4	20.0	17.0	Fernandes_Louis_E; Epstein_Caroline_G; Bobe_Alexandria_M; Bell_Joshua_S_K; Stumpe_Martin_C; Salazar_Michael_E; Salahudeen_Ameen_A; Pe_Benito_Ruth_A; McCarter_Calvin; Leibowitz_Benjamin_D; Kase_Matthew; Igartua_Catherine; Huether_Robert; Hafez_Ashraf; Beaubier_Nike; Axelson_Michael_D; Palmer_Gary_A			tempus labs, chicago, il.; tempus labs, chicago, il.; tempus labs, chicago, il.; tempus labs, chicago, il.; tempus labs, chicago, il.; tempus labs, chicago, il.; tempus labs, chicago, il.; tempus labs, chicago, il.; tempus labs, chicago, il.; tempus labs, chicago, il.; tempus labs, chicago, il.; tempus labs, chicago, il.; tempus labs, chicago, il.; tempus labs, chicago, il.; tempus labs, chicago, il.; tempus labs, chicago, il.; tempus labs, chicago, il. electronic address: publications@tempus.com.
33441554	Very low mutation burden is a feature of inflamed recurrent glioblastomas responsive to cancer immunotherapy.	10.1038/s41467-020-20469-6	Nature communications	2021	12.0	1	28.0	1.0	Beaubier_Nike			tempus labs, inc., chicago, il, 60654, usa.
33588584	Deep Neural Networks Can Predict New-Onset Atrial Fibrillation From the 12-Lead ECG and Help Identify Those at Risk of Atrial Fibrillation-Related Stroke.	10.1161/CIRCULATIONAHA.120.047829	Circulation	2021	143.0	13	22.0	5.0	Nemani_Arun; Carbonati_Tanner; Johnson_Kipp_W; Zimmerman_Noah; Hafez_Ashraf			tempus labs inc, chicago, il (a.n., t.c., k.w.j., n.z., a.h.).; tempus labs inc, chicago, il (a.n., t.c., k.w.j., n.z., a.h.).; tempus labs inc, chicago, il (a.n., t.c., k.w.j., n.z., a.h.).; tempus labs inc, chicago, il (a.n., t.c., k.w.j., n.z., a.h.).; tempus labs inc, chicago, il (a.n., t.c., k.w.j., n.z., a.h.).
33619384	The NCI Genomic Data Commons.	10.1038/s41588-021-00791-5	Nature genetics	2021	53.0	3	91.0	1.0	Pedrosa_Jesús			tempus, chicago, il, usa.
33758901	PCR assay to enhance global surveillance for SARS-CoV-2 variants of concern.	10.1101/2021.01.28.21250486	medRxiv : the preprint server for health sciences	2021			36.0	6.0	Mason_Christopher_E; Khullar_Gaurav; Metti_Jessica; Dudley_Joel_T; MacKay_Matthew_J; Nash_Megan			tempus labs, chicago, il 60654, usa.; tempus labs, chicago, il 60654, usa.; tempus labs, chicago, il 60654, usa.; tempus labs, chicago, il 60654, usa.; tempus labs, chicago, il 60654, usa.; tempus labs, chicago, il 60654, usa.
34788103	Patient similarity network of newly diagnosed multiple myeloma identifies patient subgroups with distinct genetic features and clinical implications.	10.1126/sciadv.abg9551	Science advances	2021	7.0	47	17.0	1.0	Dudley_Joel_T			tempus labs inc., chicago, il, usa.
34635154	Integrative epigenomic and high-throughput functional enhancer profiling reveals determinants of enhancer heterogeneity in gastric cancer.	10.1186/s13073-021-00970-3	Genome medicine	2021	13.0	1	24.0	1.0	White_Kevin_P			tempus labs, chicago, usa. kevin@tempus.com.
34430931	"Preview of ""Interpretable systems biomarkers predict response to immune-checkpoint inhibitors""."	10.1016/j.patter.2021.100313	Patterns (New York, N.Y.)	2021	2.0	8	1.0	1.0	Guinney_Justin			tempus labs, chicago, il, usa.
34380723	Cross-sectional study of correlates and prevalence of functional and high-risk multimorbidity in an academic HIV practice in New York City.	10.1136/bmjopen-2020-047199	BMJ open	2021	11.0	8	4.0	1.0	Mauer_Elizabeth			tempus labs, inc, new york, new york, usa.
34941024	Viral Dynamics of SARS-CoV-2 Variants in Vaccinated and Unvaccinated Persons.	10.1056/NEJMc2102507	The New England journal of medicine	2021	385.0	26	19.0	8.0	Metti_Jessica; Khullar_Gaurav; Baits_Rachel; MacKay_Matthew; Salgado_Daisy; Baker_Tim; Dudley_Joel_T; Mason_Christopher_E			tempus labs, chicago, il.; tempus labs, chicago, il.; tempus labs, chicago, il.; tempus labs, chicago, il.; tempus labs, chicago, il.; tempus labs, chicago, il.; tempus labs, chicago, il.; tempus labs, chicago, il.
34836952	Whole-genome analysis of Nigerian patients with breast cancer reveals ethnic-driven somatic evolution and distinct genomic subtypes.	10.1038/s41467-021-27079-w	Nature communications	2021	12.0	1	28.0	1.0	White_Kevin_P			tempus labs inc., chicago, il, 60654, usa.
33929890	BloodPAC Data Commons for Liquid Biopsy Data.	10.1200/CCI.20.00179	JCO clinical cancer informatics	2021	5.0		10.0	1.0	Dry_Jonathan_R			tempus labs, chicago, il.
33961632	Multiplex qPCR discriminates variants of concern to enhance global surveillance of SARS-CoV-2.	10.1371/journal.pbio.3001236	PLoS biology	2021	19.0	5	39.0	6.0	Mason_Christopher_E; Khullar_Gaurav; Metti_Jessica; Dudley_Joel_T; MacKay_Matthew_J; Nash_Megan			tempus labs, chicago, illinois, united states of america.; tempus labs, chicago, illinois, united states of america.; tempus labs, chicago, illinois, united states of america.; tempus labs, chicago, illinois, united states of america.; tempus labs, chicago, illinois, united states of america.; tempus labs, chicago, illinois, united states of america.
34643931	Review of the genomic landscape of common pediatric CNS tumors and how data sharing will continue to shape this landscape in the future.	10.1007/s11033-021-06811-1	Molecular biology reports	2021	48.0	11	2.0	1.0	Kaneva_Kristiyana			pediatric oncology development, tempus labs, inc, 600 west chicago ave, #510, chicago, il, 60654, usa. kkaneva87@gmail.com.
34320344	A pan-cancer organoid platform for precision medicine.	10.1016/j.celrep.2021.109429	Cell reports	2021	36.0	4	38.0	26.0	Larsen_Brian_M; Kannan_Madhavi; Langer_Lee_F; Leibowitz_Benjamin_D; Bentaieb_Aicha; Cancino_Andrea; Drummond_Bridgette_E; Dry_Jonathan_R; Ho_Chi-Sing; Khullar_Gaurav; Mapes_Brandon; McKinnon_Kelly_E; Metti_Jessica; Perera_Jason_F; Rand_Tim_A; Sanchez-Freire_Veronica; Shaxted_Jenna_M; Stein_Michelle_M; Streit_Michael_A; Zhang_Yilin; Venkataraman_Jagadish; Stumpe_Martin_C; White_Kevin_P; Khan_Aly_A; Igartua_Catherine; Salahudeen_Ameen_A			tempus labs, chicago, il 60654, usa.; tempus labs, chicago, il 60654, usa.; tempus labs, chicago, il 60654, usa.; tempus labs, chicago, il 60654, usa.; tempus labs, chicago, il 60654, usa.; tempus labs, chicago, il 60654, usa.; tempus labs, chicago, il 60654, usa.; tempus labs, chicago, il 60654, usa.; tempus labs, chicago, il 60654, usa.; tempus labs, chicago, il 60654, usa.; tempus labs, chicago, il 60654, usa.; tempus labs, chicago, il 60654, usa.; tempus labs, chicago, il 60654, usa.; tempus labs, chicago, il 60654, usa.; tempus labs, chicago, il 60654, usa.; tempus labs, chicago, il 60654, usa.; tempus labs, chicago, il 60654, usa.; tempus labs, chicago, il 60654, usa.; tempus labs, chicago, il 60654, usa.; tempus labs, chicago, il 60654, usa.; tempus labs, chicago, il 60654, usa.; tempus labs, chicago, il 60654, usa.; tempus labs, chicago, il 60654, usa.; tempus labs, chicago, il 60654, usa; department of pathology, biological sciences division, university of chicago, chicago, il 60637, usa. electronic address: aakhan@tempus.com.; tempus labs, chicago, il 60654, usa. electronic address: katie.igartua@tempus.com.; tempus labs, chicago, il 60654, usa. electronic address: ameen@tempus.com.
34012069	Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2021 update: a policy statement of the American College of Medical Genetics and Genomics (ACMG).	10.1038/s41436-021-01171-4	Genetics in medicine : official journal of the American College of Medical Genetics	2021	23.0	8	18.0	1.0	Vlangos_Christopher_N			tempus labs, inc., chicago, il, usa.
34357101	Somatic Tumor Profile Analysis in a Patient with Germline <i>PMS2</i> Mutation and Synchronous Ovarian and Uterine Carcinomas.	10.3390/jpm11070634	Journal of personalized medicine	2021	11.0	7	6.0	1.0	Mahon_Brett			tempus, chicago, il 60654, usa.
35602201	Predicting prostate cancer specific-mortality with artificial intelligence-based Gleason grading.	10.1038/s43856-021-00005-3	Communications medicine	2021	1.0		23.0	1.0	Stumpe_Martin_C			present address: tempus labs inc, chicago, il usa.
34215841	Validation of a liquid biopsy assay with molecular and clinical profiling of circulating tumor DNA.	10.1038/s41698-021-00202-2	NPJ precision oncology	2021	5.0	1	15.0	14.0	Finkle_Justin_D; Boulos_Hala; Driessen_Terri_M; Lo_Christine; Blidner_Richard_A; Hafez_Ashraf; Khan_Aly_A; Lozac'hmeur_Ariane; McKinnon_Kelly_E; Perera_Jason; Zhu_Wei; White_Kevin_P; Tell_Robert; Beaubier_Nike			tempus labs, chicago, il, usa.; tempus labs, chicago, il, usa.; tempus labs, chicago, il, usa.; tempus labs, chicago, il, usa.; tempus labs, chicago, il, usa.; tempus labs, chicago, il, usa.; tempus labs, chicago, il, usa.; tempus labs, chicago, il, usa.; tempus labs, chicago, il, usa.; tempus labs, chicago, il, usa.; tempus labs, chicago, il, usa.; tempus labs, chicago, il, usa.; tempus labs, chicago, il, usa. bob@tempus.com.; tempus labs, chicago, il, usa. nike.beaubier@tempus.com.
34012068	ACMG SF v3.0 list for reporting of secondary findings in clinical exome and genome sequencing: a policy statement of the American College of Medical Genetics and Genomics (ACMG).	10.1038/s41436-021-01172-3	Genetics in medicine : official journal of the American College of Medical Genetics	2021	23.0	8	18.0	1.0	Vlangos_Christopher_N			tempus labs, inc., chicago, il, usa.
34345026	Correction to: ACMG SF v3.0 list for reporting of secondary findings in clinical exome and genome sequencing: a policy statement of the American College of Medical Genetics and Genomics (ACMG).	10.1038/s41436-021-01278-8	Genetics in medicine : official journal of the American College of Medical Genetics	2021	23.0	8	18.0	1.0	Vlangos_Christopher_N			tempus labs, inc., chicago, il, usa.
34645491	Artificial intelligence enables comprehensive genome interpretation and nomination of candidate diagnoses for rare genetic diseases.	10.1186/s13073-021-00965-0	Genome medicine	2021	13.0	1	28.0	1.0	De_La_Vega_Francisco_M			current address: tempus labs inc., redwood city, ca, 94065, usa.
34007079	Author Correction: The NCI Genomic Data Commons.	10.1038/s41588-021-00883-2	Nature genetics	2021	53.0	6	91.0	1.0	Pedrosa_Jesús			tempus, chicago, il, usa.
32004563	Integrating Next-Generation Sequencing with Morphology Improves Prognostic and Biologic Classification of Spitz Neoplasms.	10.1016/j.jid.2019.12.031	The Journal of investigative dermatology	2020	140.0	8	12.0	3.0	Taxter_Timothy; Beaubier_Nike; White_Kevin			tempus labs, inc., chicago, il, illinois, usa.; tempus labs, inc., chicago, il, illinois, usa.; tempus labs, inc., chicago, il, illinois, usa.
32000215	Retrospective Cohort: Genomic Differences Between Pigmented Spindle Cell Nevi of Reed and Reed-Like Melanomas.	10.1097/DAD.0000000000001603	The American Journal of dermatopathology	2020	42.0	9	15.0	4.0	Isales_Maria_Cristina; Beaubier_Nike; Taxter_Timothy_J; White_Kevin_P			tempus labs, inc, chicago, il.; tempus labs, inc, chicago, il.; tempus labs, inc, chicago, il.; tempus labs, inc, chicago, il.
32108894	Tumor Mutational Burden From Tumor-Only Sequencing Compared With Germline Subtraction From Paired Tumor and Normal Specimens.	10.1001/jamanetworkopen.2020.0202	JAMA network open	2020	3.0	2	8.0	4.0	Huether_Robert; White_Kevin; Hoskinson_Derick; Beaubier_Nike			tempus labs, chicago, illinois.; tempus labs, chicago, illinois.; tempus labs, chicago, illinois.; tempus labs, chicago, illinois.
32282793	DRAMS: A tool to detect and re-align mixed-up samples for integrative studies of multi-omics data.	10.1371/journal.pcbi.1007522	PLoS computational biology	2020	16.0	4	14.0	1.0	White_Kevin_P			tempus labs inc, chicago, illinois, united states of america.
32364535	Genomic and epigenomic EBF1 alterations modulate TERT expression in gastric cancer.	10.1172/JCI126726	The Journal of clinical investigation	2020	130.0	6	46.0	1.0	White_Kevin			tempus labs, chicago, illinois, usa.
32393799	Prediction of mortality from 12-lead electrocardiogram voltage data using a deep neural network.	10.1038/s41591-020-0870-z	Nature medicine	2020	26.0	6	22.0	5.0	Stumpe_Martin_C; Hafez_Ashraf; Nemani_Arun; Carbonati_Tanner; Johnson_Kipp_W			tempus labs, inc., chicago, il, usa.; tempus labs, inc., chicago, il, usa.; tempus labs, inc., chicago, il, usa.; tempus labs, inc., chicago, il, usa.; tempus labs, inc., chicago, il, usa.
32484845	Contrasting model mechanisms of alanine aminotransferase (ALT) release from damaged and necrotic hepatocytes as an example of general biomarker mechanisms.	10.1371/journal.pcbi.1007622	PLoS computational biology	2020	16.0	6	8.0	1.0	Ropella_Glen_E_P			tempus dictum, inc., milwaukie, oregon, united states of america.
31542774	Integrated paired-end enhancer profiling and whole-genome sequencing reveals recurrent <i>CCNE1</i> and <i>IGF2</i> enhancer hijacking in primary gastric adenocarcinoma.	10.1136/gutjnl-2018-317612	Gut	2020	69.0	6	26.0	1.0	White_Kevin_P			tempus labs, chicago, illinois, usa.
32684305	Identification of Differential Tumor Subtypes of T1 Bladder Cancer.	10.1016/j.eururo.2020.06.048	European urology	2020	78.0	4	17.0	1.0	Taxter_Timothy_J			tempus labs, inc., chicago, il, usa.
32383249	Clinical validity of expanded carrier screening: Evaluating the gene-disease relationship in more than 200 conditions.	10.1002/humu.24033	Human mutation	2020	41.0	8	10.0	1.0	Beauchamp_Kyle			tempus, redwood city, california.
32526042	Molecular analysis of atypical deep penetrating nevus progressing to melanoma.	10.1111/cup.13775	Journal of cutaneous pathology	2020	47.0	12	8.0	1.0	Beaubier_Nike			tempus labs, inc., chicago, illinois, usa.
33242405	Clonal Hematopoiesis Before, During, and After Human Spaceflight.	10.1016/j.celrep.2020.108458	Cell reports	2020	33.0	10	20.0	1.0	Hassane_Duane_C			weill cornell medicine, new york, ny, usa; department of physiology and biophysics, weill cornell medicine, new york, 10065, usa; tempus labs inc. chicago, il, usa. electronic address: duane.hassane@gmail.com.
32728046	An integrative ENCODE resource for cancer genomics.	10.1038/s41467-020-14743-w	Nature communications	2020	11.0	1	58.0	1.0	White_Kevin_P			tempus labs, chicago, il, 60654, usa. kevin@tempus.com.
32701148	Development and Validation of a Deep Learning Algorithm for Gleason Grading of Prostate Cancer From Biopsy Specimens.	10.1001/jamaoncol.2020.2485	JAMA oncology	2020	6.0	9	26.0	1.0	Stumpe_Martin_C			now with tempus, inc, redwood shores, california.
33292397	STARRPeaker: uniform processing and accurate identification of STARR-seq active regions.	10.1186/s13059-020-02194-x	Genome biology	2020	21.0	1	11.0	5.0	Shi_Manman; Moran_Jennifer; Wall_Martha; Kyono_Yasuhiro; White_Kevin_P			tempus labs, inc., chicago, il, 60654, usa.; tempus labs, inc., chicago, il, 60654, usa.; tempus labs, inc., chicago, il, 60654, usa.; tempus labs, inc., chicago, il, 60654, usa.; tempus labs, inc., chicago, il, 60654, usa. kevin@tempus.com.
33242416	Fundamental Biological Features of Spaceflight: Advancing the Field to Enable Deep-Space Exploration.	10.1016/j.cell.2020.10.050	Cell	2020	183.0	5	38.0	1.0	Hassane_Duane			tempus labs, inc., chicago, il 60654, usa.
32721622	The advances of organic chromium based polymer gels and their application in improved oil recovery.	10.1016/j.cis.2020.102214	Advances in colloid and interface science	2020	282.0		7.0	1.0	Aidarova_Saule			key laboratory of unconventional oil & gas development (china university of petroleum (east china)), ministry of education, qingdao 266580, pr china; school of petroleum engineering, china university of petroleum (east china), qingdao 266580, pr china; kazakh-british technical university, almaty 050000, kazakhstan. electronic address: tempus_aidarova@mail.ru.
33205120	Identification of Intrinsic Drug Resistance and Its Biomarkers in High-Throughput Pharmacogenomic and CRISPR Screens.	10.1016/j.patter.2020.100065	Patterns (New York, N.Y.)	2020	1.0	5	10.0	1.0	Dry_Jonathan_R			tempus labs, boston, ma, usa.
33077832	Automated microfluidic platform for dynamic and combinatorial drug screening of tumor organoids.	10.1038/s41467-020-19058-4	Nature communications	2020	11.0	1	10.0	1.0	White_Kevin_P			tempus labs, chicago, il, 60654, usa.
33180129	Evaluation of the Use of Combined Artificial Intelligence and Pathologist Assessment to Review and Grade Prostate Biopsies.	10.1001/jamanetworkopen.2020.23267	JAMA network open	2020	3.0	11	21.0	1.0	Stumpe_Martin_C			now with tempus labs, chicago, illinois.
32728249	Expanded encyclopaedias of DNA elements in the human and mouse genomes.	10.1038/s41586-020-2493-4	Nature	2020	583.0	7818	63.0	1.0	White_Kevin_P			tempus labs, chicago, il, usa.
31034050	Genome-Wide Analysis of Glioblastoma Patients with Unexpectedly Long Survival.	10.1093/jnen/nlz025	Journal of neuropathology and experimental neurology	2019	78.0	6	16.0	1.0	Taxter_Timothy			tempus, inc., chicago, illinois.
31040929	Clinical validation of the tempus xT next-generation targeted oncology sequencing assay.	10.18632/oncotarget.26797	Oncotarget	2019	10.0	24	22.0	22.0	Beaubier_Nike; Tell_Robert; Lau_Denise; Parsons_Jerod_R; Bush_Stephen; Perera_Jason; Sorrells_Shelly; Baker_Timothy; Chang_Alan; Michuda_Jackson; Iguartua_Catherine; MacNeil_Shelley; Shah_Kaanan; Ellis_Philip; Yeatts_Kimberly; Mahon_Brett; Taxter_Timothy; Bontrager_Martin; Khan_Aly; Huether_Robert; Lefkofsky_Eric; White_Kevin_P			tempus labs inc., chicago, il 60654, usa.; tempus labs inc., chicago, il 60654, usa.; tempus labs inc., chicago, il 60654, usa.; tempus labs inc., chicago, il 60654, usa.; tempus labs inc., chicago, il 60654, usa.; tempus labs inc., chicago, il 60654, usa.; tempus labs inc., chicago, il 60654, usa.; tempus labs inc., chicago, il 60654, usa.; tempus labs inc., chicago, il 60654, usa.; tempus labs inc., chicago, il 60654, usa.; tempus labs inc., chicago, il 60654, usa.; tempus labs inc., chicago, il 60654, usa.; tempus labs inc., chicago, il 60654, usa.; tempus labs inc., chicago, il 60654, usa.; tempus labs inc., chicago, il 60654, usa.; tempus labs inc., chicago, il 60654, usa.; tempus labs inc., chicago, il 60654, usa.; tempus labs inc., chicago, il 60654, usa.; tempus labs inc., chicago, il 60654, usa.; tempus labs inc., chicago, il 60654, usa.; tempus labs inc., chicago, il 60654, usa.; tempus labs inc., chicago, il 60654, usa.
30640733	Activating Structural Alterations in MAPK Genes Are Distinct Genetic Drivers in a Unique Subgroup Of Spitzoid Neoplasms.	10.1097/PAS.0000000000001213	The American journal of surgical pathology	2019	43.0	4	10.0	3.0	Taxter_Timothy_J; Beaubier_Nike; White_Kevin			tempus labs inc., chicago, il.; tempus labs inc., chicago, il.; tempus labs inc., chicago, il.
30643118	Author Correction: Characterization of Nigerian breast cancer reveals prevalent homologous recombination deficiency and aggressive molecular features.	10.1038/s41467-018-07886-4	Nature communications	2019	10.0	1	54.0	1.0	White_Kevin_P			tempus labs, inc., chicago, il, usa. kpwhite@uchicago.edu.
30517658	Spinal Pleomorphic Xanthoastrocytoma With a QKI-RAF1 Fusion.	10.1093/jnen/nly112	Journal of neuropathology and experimental neurology	2019	78.0	1	8.0	1.0	Schwarzbach_Anna			tempus, chicago, illinois.
30864330	Integrating RNA expression and visual features for immune infiltrate prediction.		Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing	2019	24.0		6.0	1.0	Reiman_Derek			tempus labs, chicago, il 60654, usa.
30698817	Propagation of Pericentral Necrosis During Acetaminophen-Induced Liver Injury: Evidence for Early Interhepatocyte Communication and Information Exchange.	10.1093/toxsci/kfz029	Toxicological sciences : an official journal of the Society of Toxicology	2019	169.0	1	6.0	1.0	Ropella_Glen_E_P			tempus dictum, inc., milwaukie, oregon.
30898262	RNA Sequencing of the Tumor Microenvironment in Precision Cancer Immunotherapy.	10.1016/j.trecan.2019.02.006	Trends in cancer	2019	5.0	3	3.0	3.0	Lau_Denise; Bobe_Alexandria_M; Khan_Aly_A			tempus labs, chicago, il 60654, usa.; tempus labs, chicago, il 60654, usa.; tempus labs, chicago, il 60654, usa; toyota technological institute at chicago, chicago, il 60637, usa. electronic address: aakhan@ttic.edu.
30692535	Author Correction: Pan-cancer analysis of homozygous deletions in primary tumours uncovers rare tumour suppressors.	10.1038/s41467-019-08512-7	Nature communications	2019	10.0	1	18.0	1.0	White_Kevin_P			tempus labs, inc, chicago, il, usa.
30171177	Human Organoids Share Structural and Genetic Features with Primary Pancreatic Adenocarcinoma Tumors.	10.1158/1541-7786.MCR-18-0531	Molecular cancer research : MCR	2019	17.0	1	20.0	4.0	Ugolkov_Andrey; Zhang_Yilin; Roggin_Kevin; White_Kevin_P			tempus labs, chicago, illinois.; tempus labs, chicago, illinois.; department of surgery, the university of chicago medicine, chicago, illinois. kpwhite@uchicago.edu kevin@tempus.com.; tempus labs, chicago, illinois.
30696619	Tumor mutational burden and other predictive immunotherapy markers in histiocytic neoplasms.	10.1182/blood-2018-12-893917	Blood	2019	133.0	14	13.0	2.0	Lau_Denise; Nagle_Alison_M			tempus labs, chicago, il; and.; tempus labs, chicago, il; and.
30475255	Distinct Genomic Patterns in Pigmented Epithelioid Melanocytoma: A Molecular and Histologic Analysis of 16 Cases.	10.1097/PAS.0000000000001195	The American journal of surgical pathology	2019	43.0	4	12.0	3.0	Beaubier_Nike; White_Kevin; Taxter_Timothy_J			tempus labs inc., chicago, il.; tempus labs inc., chicago, il.; tempus labs inc., chicago, il.
31304394	Development and validation of a deep learning algorithm for improving Gleason scoring of prostate cancer.	10.1038/s41746-019-0112-2	NPJ digital medicine	2019	2.0		19.0	1.0	Stumpe_Martin_C			present address: ai and data science, tempus labs inc, chicago, united states.
31570899	Integrated genomic profiling expands clinical options for patients with cancer.	10.1038/s41587-019-0259-z	Nature biotechnology	2019	37.0	11	22.0	22.0	Beaubier_Nike; Bontrager_Martin; Huether_Robert; Igartua_Catherine; Lau_Denise; Tell_Robert; Bobe_Alexandria_M; Bush_Stephen; Chang_Alan_L; Hoskinson_Derick_C; Khan_Aly_A; Kudalkar_Emily; Leibowitz_Benjamin_D; Lozachmeur_Ariane; Michuda_Jackson; Parsons_Jerod; Perera_Jason_F; Salahudeen_Ameen; Shah_Kaanan_P; Taxter_Timothy; Zhu_Wei; White_Kevin_P			tempus labs, inc., chicago, il, usa.; tempus labs, inc., chicago, il, usa.; tempus labs, inc., chicago, il, usa.; tempus labs, inc., chicago, il, usa.; tempus labs, inc., chicago, il, usa.; tempus labs, inc., chicago, il, usa.; tempus labs, inc., chicago, il, usa.; tempus labs, inc., chicago, il, usa.; tempus labs, inc., chicago, il, usa.; tempus labs, inc., chicago, il, usa.; tempus labs, inc., chicago, il, usa.; tempus labs, inc., chicago, il, usa.; tempus labs, inc., chicago, il, usa.; tempus labs, inc., chicago, il, usa.; tempus labs, inc., chicago, il, usa.; tempus labs, inc., chicago, il, usa.; tempus labs, inc., chicago, il, usa.; tempus labs, inc., chicago, il, usa.; tempus labs, inc., chicago, il, usa.; tempus labs, inc., chicago, il, usa.; tempus labs, inc., chicago, il, usa.; tempus labs, inc., chicago, il, usa. kevin@tempus.com.
33869370	Benevolent and Hostile Sexism in Social Spheres: The Impact of Parents, School and Romance on Belgian Adolescents' Sexist Attitudes.	10.3389/fsoc.2019.00047	Frontiers in sociology	2019	4.0		3.0	2.0	Mastari_Laora; Spruyt_Bram			tempus omnia revelat (tor) research group, department of sociology, vrije universiteit brussel, brussels, belgium.; tempus omnia revelat (tor) research group, department of sociology, vrije universiteit brussel, brussels, belgium.
31523482	Multi-Field-of-View Deep Learning Model Predicts Nonsmall Cell Lung Cancer Programmed Death-Ligand 1 Status from Whole-Slide Hematoxylin and Eosin Images.	10.4103/jpi.jpi_24_19	Journal of pathology informatics	2019	10.0		10.0	10.0	Sha_Lingdao; Osinski_Boleslaw_L; Ho_Irvin_Y; Tan_Timothy_L; Willis_Caleb; Weiss_Hannah; Beaubier_Nike; Mahon_Brett_M; Taxter_Tim_J; Yip_Stephen_S_F			tempus labs, inc, chicago, il usa.; tempus labs, inc, chicago, il usa.; tempus labs, inc, chicago, il usa.; tempus labs, inc, chicago, il usa.; tempus labs, inc, chicago, il usa.; tempus labs, inc, chicago, il usa.; tempus labs, inc, chicago, il usa.; tempus labs, inc, chicago, il usa.; tempus labs, inc, chicago, il usa.; tempus labs, inc, chicago, il usa.
31406351	An augmented reality microscope with real-time artificial intelligence integration for cancer diagnosis.	10.1038/s41591-019-0539-7	Nature medicine	2019	25.0	9	12.0	1.0	Stumpe_Martin_C			tempus labs inc., chicago, il, usa. cmermel@google.com.
31646182	Reply: 'The importance of study design in the application of artificial intelligence methods in medicine'.	10.1038/s41746-019-0175-0	NPJ digital medicine	2019	2.0		5.0	1.0	Stumpe_Martin_C			present address: tempus labs inc, chicago, il usa.
31921487	Whole-Slide Image Focus Quality: Automatic Assessment and Impact on AI Cancer Detection.	10.4103/jpi.jpi_11_19	Journal of pathology informatics	2019	10.0		8.0	1.0	Stumpe_Martin_C			current affiliation: tempus labs, chicago, il, usa.
31173346	Germline variants and somatic mutation signatures of breast cancer across populations of African and European ancestry in the US and Nigeria.	10.1002/ijc.32498	International journal of cancer	2019	145.0	12	22.0	1.0	White_Kevin_P			tempus labs inc., chicago, il.
30128536	Association of Breast and Ovarian Cancers With Predisposition Genes Identified by Large-Scale Sequencing.	10.1001/jamaoncol.2018.2956	JAMA oncology	2019	5.0	1	17.0	1.0	Huether_Robert			tempus, chicago, illinois.
31306728	Distinct Genomic Features in a Retrospective Cohort of Mucosal, Acral and Vulvovaginal Melanomas.	10.1016/j.jaad.2019.07.017	Journal of the American Academy of Dermatology	2019			14.0	4.0	Igartua_Catherine; Beaubier_Nike; Taxter_Timothy_J; White_Kevin_P			tempus labs, inc., chicago, il.; tempus labs, inc., chicago, il.; tempus labs, inc., chicago, il.; tempus labs, inc., chicago, il.
31304402	Similar image search for histopathology: SMILY.	10.1038/s41746-019-0131-z	NPJ digital medicine	2019	2.0		14.0	1.0	Stumpe_Martin_C			present address: ai and data science, tempus labs inc, chicago, il usa.
31162949	Clinical Relevance of Noncoding Adenosine-to-Inosine RNA Editing in Multiple Human Cancers.	10.1200/CCI.18.00151	JCO clinical cancer informatics	2019	3.0		4.0	1.0	White_Kevin_P			tempus labs, chicago, il.
31544169	Prolonged Partial Response to Bevacizumab and Valproic Acid in a Patient With Glioblastoma.	10.1200/PO.18.00282	JCO precision oncology	2018	2.0		4.0	1.0	Palmer_Gary			tempus, chicago, il.
29899824	Clinical validation of the Tempus xO assay.	10.18632/oncotarget.25381	Oncotarget	2018	9.0	40	28.0	22.0	Beaubier_Nike; Tell_Robert; Huether_Robert; Bontrager_Martin; Bush_Stephen; Parsons_Jerod; Shah_Kaanan; Baker_Tim; Selkov_Gene; Taxter_Tim; Thomas_Amber; Bettis_Sam; Khan_Aly; Lau_Denise; Lee_Christina; Barber_Matthew; Frankenberger_Casey; Franzen_Amy; Weiner_Ali; Palmer_Gary; Lefkofsky_Eric; White_Kevin_P			tempus labs, inc., chicago, illinois 60654, usa.; tempus labs, inc., chicago, illinois 60654, usa.; tempus labs, inc., chicago, illinois 60654, usa.; tempus labs, inc., chicago, illinois 60654, usa.; tempus labs, inc., chicago, illinois 60654, usa.; tempus labs, inc., chicago, illinois 60654, usa.; tempus labs, inc., chicago, illinois 60654, usa.; tempus labs, inc., chicago, illinois 60654, usa.; tempus labs, inc., chicago, illinois 60654, usa.; tempus labs, inc., chicago, illinois 60654, usa.; tempus labs, inc., chicago, illinois 60654, usa.; tempus labs, inc., chicago, illinois 60654, usa.; tempus labs, inc., chicago, illinois 60654, usa.; tempus labs, inc., chicago, illinois 60654, usa.; tempus labs, inc., chicago, illinois 60654, usa.; tempus labs, inc., chicago, illinois 60654, usa.; tempus labs, inc., chicago, illinois 60654, usa.; tempus labs, inc., chicago, illinois 60654, usa.; tempus labs, inc., chicago, illinois 60654, usa.; tempus labs, inc., chicago, illinois 60654, usa.; tempus labs, inc., chicago, illinois 60654, usa.; tempus labs, inc., chicago, illinois 60654, usa.
29943666	Recurrent Glioblastoma Treated with Recombinant Poliovirus.	10.1056/NEJMoa1716435	The New England journal of medicine	2018	379.0	2	18.0	18.0	Desjardins_Annick; Gromeier_Matthias; Herndon_James_E; Beaubier_Nike; Bolognesi_Dani_P; Friedman_Allan_H; Friedman_Henry_S; McSherry_Frances; Muscat_Andrea_M; Nair_Smita; Peters_Katherine_B; Randazzo_Dina; Sampson_John_H; Vlahovic_Gordana; Harrison_William_T; McLendon_Roger_E; Ashley_David; Bigner_Darell_D			from the departments of neurosurgery (a.d., m.g., a.h.f., h.s.f., k.b.p., d.r., j.h.s., g.v., d.a., d.d.b.), biostatistics (j.e.h., f.m.), surgery (d.p.b., s.n.), and pathology (w.t.h., r.e.m.) and the preston robert tisch brain tumor center (a.d., m.g., j.e.h., d.p.b., a.h.f., h.s.f., f.m., s.n., k.b.p., d.r., j.h.s., g.v., w.t.h., r.e.m., d.a., d.d.b.), duke university medical center, and istari oncology (d.p.b.) - all in durham, nc; tempus labs, chicago (n.b.); and the school of medicine, deakin university, geelong, vic, australia (a.m.m.).; from the departments of neurosurgery (a.d., m.g., a.h.f., h.s.f., k.b.p., d.r., j.h.s., g.v., d.a., d.d.b.), biostatistics (j.e.h., f.m.), surgery (d.p.b., s.n.), and pathology (w.t.h., r.e.m.) and the preston robert tisch brain tumor center (a.d., m.g., j.e.h., d.p.b., a.h.f., h.s.f., f.m., s.n., k.b.p., d.r., j.h.s., g.v., w.t.h., r.e.m., d.a., d.d.b.), duke university medical center, and istari oncology (d.p.b.) - all in durham, nc; tempus labs, chicago (n.b.); and the school of medicine, deakin university, geelong, vic, australia (a.m.m.).; from the departments of neurosurgery (a.d., m.g., a.h.f., h.s.f., k.b.p., d.r., j.h.s., g.v., d.a., d.d.b.), biostatistics (j.e.h., f.m.), surgery (d.p.b., s.n.), and pathology (w.t.h., r.e.m.) and the preston robert tisch brain tumor center (a.d., m.g., j.e.h., d.p.b., a.h.f., h.s.f., f.m., s.n., k.b.p., d.r., j.h.s., g.v., w.t.h., r.e.m., d.a., d.d.b.), duke university medical center, and istari oncology (d.p.b.) - all in durham, nc; tempus labs, chicago (n.b.); and the school of medicine, deakin university, geelong, vic, australia (a.m.m.).; from the departments of neurosurgery (a.d., m.g., a.h.f., h.s.f., k.b.p., d.r., j.h.s., g.v., d.a., d.d.b.), biostatistics (j.e.h., f.m.), surgery (d.p.b., s.n.), and pathology (w.t.h., r.e.m.) and the preston robert tisch brain tumor center (a.d., m.g., j.e.h., d.p.b., a.h.f., h.s.f., f.m., s.n., k.b.p., d.r., j.h.s., g.v., w.t.h., r.e.m., d.a., d.d.b.), duke university medical center, and istari oncology (d.p.b.) - all in durham, nc; tempus labs, chicago (n.b.); and the school of medicine, deakin university, geelong, vic, australia (a.m.m.).; from the departments of neurosurgery (a.d., m.g., a.h.f., h.s.f., k.b.p., d.r., j.h.s., g.v., d.a., d.d.b.), biostatistics (j.e.h., f.m.), surgery (d.p.b., s.n.), and pathology (w.t.h., r.e.m.) and the preston robert tisch brain tumor center (a.d., m.g., j.e.h., d.p.b., a.h.f., h.s.f., f.m., s.n., k.b.p., d.r., j.h.s., g.v., w.t.h., r.e.m., d.a., d.d.b.), duke university medical center, and istari oncology (d.p.b.) - all in durham, nc; tempus labs, chicago (n.b.); and the school of medicine, deakin university, geelong, vic, australia (a.m.m.).; from the departments of neurosurgery (a.d., m.g., a.h.f., h.s.f., k.b.p., d.r., j.h.s., g.v., d.a., d.d.b.), biostatistics (j.e.h., f.m.), surgery (d.p.b., s.n.), and pathology (w.t.h., r.e.m.) and the preston robert tisch brain tumor center (a.d., m.g., j.e.h., d.p.b., a.h.f., h.s.f., f.m., s.n., k.b.p., d.r., j.h.s., g.v., w.t.h., r.e.m., d.a., d.d.b.), duke university medical center, and istari oncology (d.p.b.) - all in durham, nc; tempus labs, chicago (n.b.); and the school of medicine, deakin university, geelong, vic, australia (a.m.m.).; from the departments of neurosurgery (a.d., m.g., a.h.f., h.s.f., k.b.p., d.r., j.h.s., g.v., d.a., d.d.b.), biostatistics (j.e.h., f.m.), surgery (d.p.b., s.n.), and pathology (w.t.h., r.e.m.) and the preston robert tisch brain tumor center (a.d., m.g., j.e.h., d.p.b., a.h.f., h.s.f., f.m., s.n., k.b.p., d.r., j.h.s., g.v., w.t.h., r.e.m., d.a., d.d.b.), duke university medical center, and istari oncology (d.p.b.) - all in durham, nc; tempus labs, chicago (n.b.); and the school of medicine, deakin university, geelong, vic, australia (a.m.m.).; from the departments of neurosurgery (a.d., m.g., a.h.f., h.s.f., k.b.p., d.r., j.h.s., g.v., d.a., d.d.b.), biostatistics (j.e.h., f.m.), surgery (d.p.b., s.n.), and pathology (w.t.h., r.e.m.) and the preston robert tisch brain tumor center (a.d., m.g., j.e.h., d.p.b., a.h.f., h.s.f., f.m., s.n., k.b.p., d.r., j.h.s., g.v., w.t.h., r.e.m., d.a., d.d.b.), duke university medical center, and istari oncology (d.p.b.) - all in durham, nc; tempus labs, chicago (n.b.); and the school of medicine, deakin university, geelong, vic, australia (a.m.m.).; from the departments of neurosurgery (a.d., m.g., a.h.f., h.s.f., k.b.p., d.r., j.h.s., g.v., d.a., d.d.b.), biostatistics (j.e.h., f.m.), surgery (d.p.b., s.n.), and pathology (w.t.h., r.e.m.) and the preston robert tisch brain tumor center (a.d., m.g., j.e.h., d.p.b., a.h.f., h.s.f., f.m., s.n., k.b.p., d.r., j.h.s., g.v., w.t.h., r.e.m., d.a., d.d.b.), duke university medical center, and istari oncology (d.p.b.) - all in durham, nc; tempus labs, chicago (n.b.); and the school of medicine, deakin university, geelong, vic, australia (a.m.m.).; from the departments of neurosurgery (a.d., m.g., a.h.f., h.s.f., k.b.p., d.r., j.h.s., g.v., d.a., d.d.b.), biostatistics (j.e.h., f.m.), surgery (d.p.b., s.n.), and pathology (w.t.h., r.e.m.) and the preston robert tisch brain tumor center (a.d., m.g., j.e.h., d.p.b., a.h.f., h.s.f., f.m., s.n., k.b.p., d.r., j.h.s., g.v., w.t.h., r.e.m., d.a., d.d.b.), duke university medical center, and istari oncology (d.p.b.) - all in durham, nc; tempus labs, chicago (n.b.); and the school of medicine, deakin university, geelong, vic, australia (a.m.m.).; from the departments of neurosurgery (a.d., m.g., a.h.f., h.s.f., k.b.p., d.r., j.h.s., g.v., d.a., d.d.b.), biostatistics (j.e.h., f.m.), surgery (d.p.b., s.n.), and pathology (w.t.h., r.e.m.) and the preston robert tisch brain tumor center (a.d., m.g., j.e.h., d.p.b., a.h.f., h.s.f., f.m., s.n., k.b.p., d.r., j.h.s., g.v., w.t.h., r.e.m., d.a., d.d.b.), duke university medical center, and istari oncology (d.p.b.) - all in durham, nc; tempus labs, chicago (n.b.); and the school of medicine, deakin university, geelong, vic, australia (a.m.m.).; from the departments of neurosurgery (a.d., m.g., a.h.f., h.s.f., k.b.p., d.r., j.h.s., g.v., d.a., d.d.b.), biostatistics (j.e.h., f.m.), surgery (d.p.b., s.n.), and pathology (w.t.h., r.e.m.) and the preston robert tisch brain tumor center (a.d., m.g., j.e.h., d.p.b., a.h.f., h.s.f., f.m., s.n., k.b.p., d.r., j.h.s., g.v., w.t.h., r.e.m., d.a., d.d.b.), duke university medical center, and istari oncology (d.p.b.) - all in durham, nc; tempus labs, chicago (n.b.); and the school of medicine, deakin university, geelong, vic, australia (a.m.m.).; from the departments of neurosurgery (a.d., m.g., a.h.f., h.s.f., k.b.p., d.r., j.h.s., g.v., d.a., d.d.b.), biostatistics (j.e.h., f.m.), surgery (d.p.b., s.n.), and pathology (w.t.h., r.e.m.) and the preston robert tisch brain tumor center (a.d., m.g., j.e.h., d.p.b., a.h.f., h.s.f., f.m., s.n., k.b.p., d.r., j.h.s., g.v., w.t.h., r.e.m., d.a., d.d.b.), duke university medical center, and istari oncology (d.p.b.) - all in durham, nc; tempus labs, chicago (n.b.); and the school of medicine, deakin university, geelong, vic, australia (a.m.m.).; from the departments of neurosurgery (a.d., m.g., a.h.f., h.s.f., k.b.p., d.r., j.h.s., g.v., d.a., d.d.b.), biostatistics (j.e.h., f.m.), surgery (d.p.b., s.n.), and pathology (w.t.h., r.e.m.) and the preston robert tisch brain tumor center (a.d., m.g., j.e.h., d.p.b., a.h.f., h.s.f., f.m., s.n., k.b.p., d.r., j.h.s., g.v., w.t.h., r.e.m., d.a., d.d.b.), duke university medical center, and istari oncology (d.p.b.) - all in durham, nc; tempus labs, chicago (n.b.); and the school of medicine, deakin university, geelong, vic, australia (a.m.m.).; from the departments of neurosurgery (a.d., m.g., a.h.f., h.s.f., k.b.p., d.r., j.h.s., g.v., d.a., d.d.b.), biostatistics (j.e.h., f.m.), surgery (d.p.b., s.n.), and pathology (w.t.h., r.e.m.) and the preston robert tisch brain tumor center (a.d., m.g., j.e.h., d.p.b., a.h.f., h.s.f., f.m., s.n., k.b.p., d.r., j.h.s., g.v., w.t.h., r.e.m., d.a., d.d.b.), duke university medical center, and istari oncology (d.p.b.) - all in durham, nc; tempus labs, chicago (n.b.); and the school of medicine, deakin university, geelong, vic, australia (a.m.m.).; from the departments of neurosurgery (a.d., m.g., a.h.f., h.s.f., k.b.p., d.r., j.h.s., g.v., d.a., d.d.b.), biostatistics (j.e.h., f.m.), surgery (d.p.b., s.n.), and pathology (w.t.h., r.e.m.) and the preston robert tisch brain tumor center (a.d., m.g., j.e.h., d.p.b., a.h.f., h.s.f., f.m., s.n., k.b.p., d.r., j.h.s., g.v., w.t.h., r.e.m., d.a., d.d.b.), duke university medical center, and istari oncology (d.p.b.) - all in durham, nc; tempus labs, chicago (n.b.); and the school of medicine, deakin university, geelong, vic, australia (a.m.m.).; from the departments of neurosurgery (a.d., m.g., a.h.f., h.s.f., k.b.p., d.r., j.h.s., g.v., d.a., d.d.b.), biostatistics (j.e.h., f.m.), surgery (d.p.b., s.n.), and pathology (w.t.h., r.e.m.) and the preston robert tisch brain tumor center (a.d., m.g., j.e.h., d.p.b., a.h.f., h.s.f., f.m., s.n., k.b.p., d.r., j.h.s., g.v., w.t.h., r.e.m., d.a., d.d.b.), duke university medical center, and istari oncology (d.p.b.) - all in durham, nc; tempus labs, chicago (n.b.); and the school of medicine, deakin university, geelong, vic, australia (a.m.m.).; from the departments of neurosurgery (a.d., m.g., a.h.f., h.s.f., k.b.p., d.r., j.h.s., g.v., d.a., d.d.b.), biostatistics (j.e.h., f.m.), surgery (d.p.b., s.n.), and pathology (w.t.h., r.e.m.) and the preston robert tisch brain tumor center (a.d., m.g., j.e.h., d.p.b., a.h.f., h.s.f., f.m., s.n., k.b.p., d.r., j.h.s., g.v., w.t.h., r.e.m., d.a., d.d.b.), duke university medical center, and istari oncology (d.p.b.) - all in durham, nc; tempus labs, chicago (n.b.); and the school of medicine, deakin university, geelong, vic, australia (a.m.m.).
29662209	Dynamic coupling between conformations and nucleotide states in DNA gyrase.	10.1038/s41589-018-0037-0	Nature chemical biology	2018	14.0	6	7.0	1.0	Fernandes_Louis_E			tempus, inc., chicago, il, usa.
29728604	Integrated molecular subtyping defines a curable oligometastatic state in colorectal liver metastasis.	10.1038/s41467-018-04278-6	Nature communications	2018	9.0	1	25.0	1.0	White_Kevin_P			tempus labs, chicago, il, 60654, usa.
29794873	Genomic Fusions in Pigmented Spindle Cell Nevus of Reed.	10.1097/PAS.0000000000001074	The American journal of surgical pathology	2018	42.0	8	12.0	4.0	Igartua_Catherine; Taxter_Timothy; Beaubier_Nike; White_Kevin			tempus labs inc., chicago, il.; tempus labs inc., chicago, il.; tempus labs inc., chicago, il.; tempus labs inc., chicago, il.
29279606	Nuclear receptors in cancer - uncovering new and evolving roles through genomic analysis.	10.1038/nrg.2017.102	Nature reviews. Genetics	2018	19.0	3	3.0	1.0	White_Kevin_P			tempus labs, 600 west chicago ave., chicago, illinois 60654, usa.
30311380	Gene-specific criteria for PTEN variant curation: Recommendations from the ClinGen PTEN Expert Panel.	10.1002/humu.23636	Human mutation	2018	39.0	11	17.0	1.0	Huether_Robert			tempus labs, chicago, illinois.
30327465	Characterization of Nigerian breast cancer reveals prevalent homologous recombination deficiency and aggressive molecular features.	10.1038/s41467-018-06616-0	Nature communications	2018	9.0	1	54.0	1.0	White_Kevin_P			tempus labs inc., chicago, il, usa. kpwhite@uchicago.edu.
30545964	The transcription factor POU3F2 regulates a gene coexpression network in brain tissue from patients with psychiatric disorders.	10.1126/scitranslmed.aat8178	Science translational medicine	2018	10.0	472	27.0	1.0	White_Kevin_P			tempus labs inc., chicago, il, usa.
29434053	A Model Mechanism-Based Explanation of an In Vitro-In Vivo Disconnect for Improving Extrapolation and Translation.	10.1124/jpet.117.245019	The Journal of pharmacology and experimental therapeutics	2018	365.0	1	4.0	4.0	Smith_Andrew_K; Xu_Yanli; Ropella_Glen_E_P; Hunt_C_Anthony			bioengineering and therapeutic sciences, university of california, san francisco, california (a.k.s., y.x., c.a.h.); and tempus dictum, inc., milwaukie, oregon (g.e.p.r.).; bioengineering and therapeutic sciences, university of california, san francisco, california (a.k.s., y.x., c.a.h.); and tempus dictum, inc., milwaukie, oregon (g.e.p.r.).; bioengineering and therapeutic sciences, university of california, san francisco, california (a.k.s., y.x., c.a.h.); and tempus dictum, inc., milwaukie, oregon (g.e.p.r.).; bioengineering and therapeutic sciences, university of california, san francisco, california (a.k.s., y.x., c.a.h.); and tempus dictum, inc., milwaukie, oregon (g.e.p.r.) a.hunt@ucsf.edu.
30559362	Author Correction: Pan-cancer analysis of homozygous deletions in primary tumours uncovers rare tumour suppressors.	10.1038/s41467-018-07842-2	Nature communications	2018	9.0	1	18.0	1.0	White_Kevin_P			tempus labs, inc., chicago, il, usa.
30545965	The <i>DGCR5</i> long noncoding RNA may regulate expression of several schizophrenia-related genes.	10.1126/scitranslmed.aat6912	Science translational medicine	2018	10.0	472	17.0	1.0	White_Kevin_P			tempus labs inc., chicago, il 60654, usa.
30425251	Author Correction: Integrated molecular subtyping defines a curable oligometastatic state in colorectal liver metastasis.	10.1038/s41467-018-07303-w	Nature communications	2018	9.0	1	25.0	1.0	White_Kevin_P			tempus labs, chicago, il 60654, usa.
28263985	Robust stratification of breast cancer subtypes using differential patterns of transcript isoform expression.	10.1371/journal.pgen.1006589	PLoS genetics	2017	13.0	3	9.0	1.0	White_Kevin_P			tempus labs, inc. chicago, il 60654, united states of america.
28052920	Evolution of transcript modification by <i>N</i><sup>6</sup>-methyladenosine in primates.	10.1101/gr.212563.116	Genome research	2017	27.0	3	8.0	1.0	White_Kevin_P			tempus health, incorporated, chicago, illinois 60654, usa.
29089486	Pan-cancer analysis of homozygous deletions in primary tumours uncovers rare tumour suppressors.	10.1038/s41467-017-01355-0	Nature communications	2017	8.0	1	18.0	1.0	White_Kevin_P			tempus labs, inc., chicago, il, usa.
29151363	Functional assessment of human enhancer activities using whole-genome STARR-sequencing.	10.1186/s13059-017-1345-5	Genome biology	2017	18.0	1	6.0	1.0	White_Kevin_P			tempus labs, 600 west chicago ave., chicago, il, 60654, usa. kpwhite@uchicago.edu.
31245555	The science of Learning Health Systems: Foundations for a new journal.	10.1002/lrh2.10020	Learning health systems	2017	1.0	1	7.0	1.0	Silverstein_Jonathan_C			medical informatics tempus and kanter health foundation chicago illinois.
29061142	Systematic identification of regulatory variants associated with cancer risk.	10.1186/s13059-017-1322-z	Genome biology	2017	18.0	1	9.0	1.0	White_Kevin_P			tempus labs, inc., chicago, illinois, 60654, finland. kpwhite@uchicago.edu.
27984590	Competing Mechanistic Hypotheses of Acetaminophen-Induced Hepatotoxicity Challenged by Virtual Experiments.	10.1371/journal.pcbi.1005253	PLoS computational biology	2016	12.0	12	7.0	1.0	Ropella_Glen_E_P			tempus dictum, inc., milwaukie, or, united states of america.
27931250	Tracing the origin of disseminated tumor cells in breast cancer using single-cell sequencing.		Genome biology	2016	17.0	1	20.0	1.0	White_Kevin_P			tempus labs, chicago, il, 60654, usa. kpwhite@uchicago.edu.
27614579	A novel high-throughput multi-parameter flow cytometry based method for monitoring and rapid characterization of microbiome dynamics in anaerobic systems.	10.1016/j.biortech.2016.08.076	Bioresource technology	2016	220.0		6.0	1.0	Dolatowski_William			tempus health, inc., 600 w chicago st, floor 7 light bank office, chicago, il 60654, usa. electronic address: will@tempus.com.
27227433	Virtual Experiments Enable Exploring and Challenging Explanatory Mechanisms of Immune-Mediated P450 Down-Regulation.	10.1371/journal.pone.0155855	PloS one	2016	11.0	5	3.0	1.0	Ropella_Glen_E_P			tempus dictum, inc., portland, oregon, united states of america.
26839017	A cell-centered, agent-based framework that enables flexible environment granularities.	10.1186/s12976-016-0030-9	Theoretical biology & medical modelling	2016	13.0		3.0	1.0	Ropella_Glen_Ep			tempus dictum, inc., milwaukie, or, usa.
21129207	Cloud computing and validation of expandable in silico livers.	10.1186/1752-0509-4-168	BMC systems biology	2010	4.0		2.0	1.0	Ropella_Glen_E_P			tempus dictum, inc., portland, or 97202, usa.
17100909	Scanning electron microscopy and transmission electron microscopy microstructural investigation of high-speed tool steel after Nd:YAG pulsed laser melting.		Journal of microscopy	2006	224.0	Pt 1	4.0	1.0	Kac_S			faculty of metallurgy and materials science, university of mining and metallurgy, 30 mickiewicza ave., 30-059 krakow, poland. skac@tempus.metal.agh.edu.pl
17100905	Structural analyses of Nd-doped CeO thin films deposited by pulsed laser deposition.		Journal of microscopy	2006	224.0	Pt 1	6.0	1.0	Kopia_A			faculty of metallurgy and materials science, agh university of science and technology, 30 mickiewicza avenue, 30-059 cracow, poland. kopia@tempus.metal.agh.edu.pl
17100899	Transmission electron microscopy study of crystallization in Fe-Si-B-Cr-C amorphous alloy.		Journal of microscopy	2006	224.0	Pt 1	4.0	1.0	Kozieł_T			university of science and technology, faculty of metallurgy and materials science, al. mickiewicza 30, 30-059 cracow, poland. tkoziel@tempus.metal.agh.edu.pl
10387355	Online insurance eligibility verification in scheduling. Where do your patients enter the healthcare process?		The NAHAM management journal	1998	24.0	5	1.0	1.0	Lang_M			tempus software, inc., jacksonville, fl, usa.
10180237	Technology is expanding healthcare access.		The NAHAM management journal	1998	24.0	3	1.0	1.0	Lang_M			tempus software, inc., jacksonville, fl, usa.
31754638	Erratum: Publisher Correction: Development and validation of a deep learning algorithm for improving Gleason scoring of prostate cancer.	10.1038/s41746-019-0196-8	NPJ digital medicine		2.0		19.0	1.0	Stumpe_Martin_C			present address: ai and data science, tempus labs inc, chicago, united states.
31169780	Competence-Based Curriculum Development in Nursing Education: A Story From the Western Balkans.	10.1097/01.NEP.0000000000000521	Nursing education perspectives		40.0	6	10.0	1.0	Bokonjić_Dejan			about the authors dejan bokonjić, phd, and maja račić, phd, are associate professors, faculty of medicine, university of east sarajevo, foča, bosnia and herzegovina. srdjan mašić, msph, is with the faculty of medicine, university of east sarajevo. mirza oruč, msd, rn, is an instructor, faculty of medicine, university of zenica, zenica, bosnia and herzegovina. lubica rybarova, rn, phs, is a professor, faculty of health care, university of prešov, prešov, slovakia. kristina vidović, msd, rn, is an instructor, university of mostar, mostar, bosnia and herzegovina. belinda drieghe, bscn, rn, is an instructor, university college odisee, brussels, belgium. johan van wieren, phd, rn, is an instructor, hanze university of applied sciences, groningen, the netherlands. erard çurçija, bscn, rn, is an instructor, university of shkodra, lugić gurakuqi, shkodra, albania. luis seiti, bscn, rn, is an instructor, eqrem çabej university of gjirokastra, gjirokastra, albania. this article was developed on the basis of the tempus project competency-based curriculum reform in nursing and caring in western balkan universities (544169-tempus-1-2013-1-be-tempus-jpcr). the authors are grateful to annette schuster, bn, macp, and elizabeth klaassen for their help in editing the article. for more information, contact maja račić at maja.racic@ues.rs.ba.
9471527	[Entropy in the assessment of diagnostic importance of changes in urine].		Medicinski pregled		50.0	9-10	2.0	1.0	Tepavcević_D			univerzitet u novom sadu, centar za univerzitetske studije yuee tempus centar.
